Three experimental drugs designed to thwart HIV have performed well in early tests on AIDS patients. If further testing supports these preliminary findings, the drugs might serve as able stand-ins for existing drugs in patients whose HIV becomes resistant to existing therapies.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.